Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CBT for insomnia (CBT-I) is considered the first-line treatment for insomnia (557) and outperforms pharmacological interventions, in particular with respect to maintenance of therapeutic effects at long-term follow-up (270, 513).”
From The Sleep-Immune Crosstalk in Health and Disease (2019) · cites this paper as [557]
Citations
Cites
Aspirin Selectively Inhibits Prostaglandin Production in Human Platelets
SMITH, J. B., & WILLIS, A. L. (1971) · Nature New Biology · doi:10.1038/newbio231235a0 · Cited by 1,521
Indomethacin and Aspirin abolish Prostaglandin Release from the Spleen
FERREIRA, S. H., MONCADA, S., & VANE, J. R. (1971) · Nature New Biology · doi:10.1038/newbio231237a0 · Cited by 941
Self-citationProstaglandins: Their Disappearance from and Release into the Circulation
FERREIRA, S. H., & VANE, J. R. (1967) · Nature · doi:10.1038/216868a0 · Cited by 892
Self-citationRelease of Additional Factors in Anaphylaxis and its Antagonism by Anti-inflammatory Drugs
PIPER, P. J., & VANE, J. R. (1969) · Nature · doi:10.1038/223029a0 · Cited by 880
Self-citationA SENSITIVE METHOD FOR THE ASSAY OF 5‐HYDROXYTRYPTAMINE
VANE, J. R. (1957) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1957.tb00146.x · Cited by 772
Self-citationTHE PROSTAGLANDINS: A FAMILY OF BIOLOGICALLY ACTIVE LIPIDS
BERGSTRÖM, S., CARLSON, L. A., & WEEKS, J. R. (1968) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)07108-x · Cited by 634
Prostaglandins released by the Spleen
Gilmore, N. J., Vane, J. R., & Wyllie, J. H. (1968) · Nature · doi:10.1038/2181135a0 · Cited by 548
Self-citationProstaglandins and related factors: XIX. Thin-layer chromatography of prostaglandins
Gréen, K., & Samuelsson, B. (1964) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40270-6 · Cited by 476
Cutaneous reactions to intradermal prostaglandins
Crunkhorn, P., & Willis, A. L. (1971) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1971.tb09934.x · Cited by 348
The enzymic conversion of all‐cis 8,11,14‐eicosatrienoic acid into prostaglandin E1
Nugteren, D. H., Beerthuis, R. K., & van Dorp, D. A. (1966) · Recueil des Travaux Chimiques des Pays-Bas · doi:10.1002/recl.19660850412 · Cited by 339
Research works printed but not linked: 11
- Jacques, R., Helv. Physiol. Pharmacol. Acta, 23, 156 (1965).
- Berry, P. A., thesis, Council for National Academic Awards, London, 91 (1966).
- Vargaftig, B. B., and Dao, N., Pharmacology (in the press).
- Piper, P. J., and Vane, J. R., in Prostaglandins (edit. by Ramwell, P., and Shaw, J.) (NY Acad. Sci., in the press, 1971).
- Willis, A. L., Brit. J. Pharmacol., 40, 583P (1970).
- Milton, A. S., and Wendlandt, S. J., J. Physiol., 207, 76P (1970).
- Feldberg, W., and Saxena, P. N., J. Physiol. (in the press, 1971).
- Willis, A. L., in Prostaglandins, Peptides and Amines (edit. by Mantegazza, P., and Horton, E. W.), 31 (Academic Press, London, 1969).
- Collier, H. O. J., Nature (in the press).
- Goodman, L. S., and Gilman, A., The Pharmacological Basis ofTherapeutics, fourth ed. (Collier-Macmillan, London, 1970).
- Hucker, H. B., Zacchei, A. G., Cox, S. V., Brodie, D. A., and Cantwell, N. H. R., J. Pharmac. Exp. Therap., 153, 237 (1966).
Cited by
Items 401–500 of 1,039
Aspirin, platelets, and thrombosis: theory and practice
Roth, G., & Calverley, D. (1994) · Blood · doi:10.1182/blood.v83.4.885.885 · Cited by 232
Sandborn, W. J., Stenson, W. F., Brynskov, J., Lorenz, R. G., Steidle, G. M., Robbins, J. L., Kent, J. D., & Bloom, B. J. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2005.12.002 · Cited by 231
PROSTAGLANDIN SYNTHETASE INHIBITORS: Drugs which affect arachidonic acid metabolism
Whittle, B. J. R. (1979) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016347909157785 · Cited by 231
Langenbach, R., Loftin, C., Lee, C., & Tiano, H. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00158-6 · Cited by 230
Scarpignato, C., & Hunt, R. H. (2010) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2010.08.010 · Cited by 230
Regioselective and stereoselective metabolism of ibuprofen by human cytochrome P450 2C
Hamman, M. A., Thompson, G. A., & Hall, S. D. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00143-3 · Cited by 230
Effect of Indomethacin on Fracture Healing in Rats
Rø, J., Sudmann, E., & Marton, P. F. (1976) · Acta Orthopaedica Scandinavica · doi:10.3109/17453677608988744 · Cited by 230
Is resolution the end of inflammation?
Feehan, K. T., & Gilroy, D. W. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.01.006 · Cited by 229
Gran, L. (1973) · Acta Pharmacologica et Toxicologica · doi:10.1111/j.1600-0773.1973.tb01541.x · Cited by 229
Zhang, Y., Shaffer, A., Portanova, J., Seibert, K., & Isakson, P. C. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37166-6 · Cited by 229
The mode of action of aspirin and similar compounds
Vane, J. R. (1976) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(76)90181-0 · Cited by 229
Self-citationCOLLIER, H. O. J., FRANCIS, D. L., & SCHNEIDER, C. (1972) · Nature · doi:10.1038/237220a0 · Cited by 229
The COXIB Experience: A Look in the Rearview Mirror
Marnett, L. J. (2009) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.011008.145638 · Cited by 228
Prostaglandin as a Mediator of Bone Resorption Induced by Experimental Tooth Movement in Rats
Yamasaki, K., Miura, F., & Suda, T. (1980) · Journal of Dental Research · doi:10.1177/00220345800590101301 · Cited by 227
Pharmacological Properties of Diclofenac Sodium and Its Metabolites
Menassé, R., Hedwall, P. R., Kraetz, J., Pericin, C., Riesterer, L., Sallmann, A., Ziel, R., & Jaques, R. (1978) · Scandinavian Journal of Rheumatology · doi:10.3109/03009747809097211 · Cited by 227
Pleskow, W. W., Stevenson, D. D., Mathison, D. A., Simon, R. A., Schatz, M. X., & Zeiger, R. S. (1982) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(82)90081-1 · Cited by 227
Gasparini, L., Ongini, E., & Wenk, G. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02743.x · Cited by 226
Rao, C., & Reddy, B. (2004) · Current Cancer Drug Targets · doi:10.2174/1568009043481632 · Cited by 225
Cardiovascular Reflex Control by Afferent Fibers from Skeletal Muscle Receptors
Mitchell, J. H., & Schmidt, R. F. (1983) · Comprehensive Physiology · doi:10.1002/cphy.cp020317 · Cited by 224
Origin, pattern, and mechanism of bile duct proliferation following biliary obstruction in the rat
Slott, P. A., Liu, M. H., & Tavoloni, N. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)91030-a · Cited by 224
Siegel, M. I., McConnell, R. T., & Cuatrecasas, P. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.8.3774 · Cited by 224
Paracetamol (acetaminophen): A familiar drug with an unexplained mechanism of action
Ayoub, S. S. (2021) · Temperature · doi:10.1080/23328940.2021.1886392 · Cited by 223
PALMER, M. A., PIPER, P. J., & VANE, J. R. (1973) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1973.tb08368.x · Cited by 223
Self-citationTerragno, N. A., Terragno, D. A., & McGiff, J. C. (1977) · Circulation Research · doi:10.1161/01.res.40.6.590 · Cited by 223
Prostaglandins in Health and Disease: An Overview
Miller, S. B. (2006) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2006.03.005 · Cited by 222
Brooks, P., Emery, P., Evans, J. F., Fenner, H., Hawkey, C. J., Patrono, C., Smolen, J., Breedveld, F., Day, R., Dougados, M., et al. (1999) · Rheumatology · doi:10.1093/rheumatology/38.8.779 · Cited by 222
Molecular targets of aspirin and cancer prevention
Alfonso, L., Ai, G., Spitale, R. C., & Bhat, G. J. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.271 · Cited by 222
“…| DOI:10.1038/bjc.2014.271 61 PROPOSED MECHANISMS OF ACTION Aspirin’s molecular mechanism of action was discovered in the 1970s when it was demonstrated that it irreversibly acetylates and inactivates the cyclooxygenase enzyme (prostaglandin H-synthase) (Vane, 1971; Roth et al, 1975).”
InfluentialHiggs, G. A., Salmon, J. A., Henderson, B., & Vane, J. R. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.5.1417 · Cited by 222
Self-citationFETAL EFFECTS OF REGULAR SALICYLATE INGESTION IN PREGNANCY
TURNER, G. M., & Collins, E. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92778-6 · Cited by 221
Loftin, C. D., Trivedi, D. B., Tiano, H. F., Clark, J. A., Lee, C. A., Epstein, J. A., Morham, S. G., Breyer, M. D., Nguyen, M., Hawkins, B. M., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.3.1059 · Cited by 219
Modes of action of aspirin-like drugs.
Abramson, S., Korchak, H., Ludewig, R., Edelson, H., Haines, K., Levin, R. I., Herman, R., Rider, L., Kimmel, S., & Weissmann, G. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.21.7227 · Cited by 219
Meloxican: Influence on arachidonic acid metabolism
Engelhardt, G., Bögel, R., Schnitzler, C., & Utzmann, R. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)02110-8 · Cited by 218
Koga, T., Takata, Y., Kobayashi, K., Takishita, S., Yamashita, Y., & Fujishima, M. (1989) · Hypertension · doi:10.1161/01.hyp.14.5.542 · Cited by 218
Prostaglandin E as the neural mediator of the febrile response.
Stitt, J. T. (1986) · PubMed Central · Cited by 218
Tomlinson, R. V., Ringold, H. J., Qureshi, M. C., & Forchielli, E. (1972) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(72)80174-8 · Cited by 218
Tozkoparan, B., Küpeli, E., Yeşilada, E., & Ertan, M. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.11.029 · Cited by 217
Liang, Y.-C., Tsai, S.-H., Tsai, D.-C., Lin-Shiau, S.-Y., & Lin, J.-K. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02393-6 · Cited by 217
Cyclooxygenase-2 as a target for anticancer drug development
Méric, J.-B., Rottey, S., Olaussen, K., Soria, J.-C., Khayat, D., Rixe, O., & Spano, J.-P. (2006) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2006.01.003 · Cited by 217
Ligumsky, M., Karmeli, F., Sharon, P., Zor, U., Cohen, F., & Rachmilewitz, D. (1981) · Gastroenterology · doi:10.1016/0016-5085(81)90594-1 · Cited by 217
Ethanol stimulates formation of leukotriene C4 in rat gastric mucosa
Peskar, B. M., Lange, K., Hoppe, U., & Peskar, B. A. (1986) · Prostaglandins · doi:10.1016/0090-6980(86)90054-7 · Cited by 217
Chemical and Biological Studies on Indomethacin, Sulindac and their Analogs
Shen, T.-Y., & Winter, C. A. (1977) · Advances in Drug Research · doi:10.1016/b978-0-12-013312-3.50007-8 · Cited by 217
Alzheimer’s disease as an inflammatory disease
Bolós, M., Perea, J. R., & Avila, J. (2017) · BioMolecular Concepts · doi:10.1515/bmc-2016-0029 · Cited by 216
“Ibuprofen is a NSAID and therefore has the capacity to inhibit COX1 and COX2.”
BackgroundNSAIDs Inhibit Tumorigenesis, but How?
Gurpinar, E., Grizzle, W. E., & Piazza, G. A. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1573 · Cited by 216
“that aspirin inhibits inflammation by suppressing PG synthesis (6), whereas COX inhibition was later shown to be responsible for this effect (7).”
Stevenson, D. D. (1984) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(84)90115-5 · Cited by 216
Cherny, N. I. (2000) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.50.2.70 · Cited by 216
Ferreri, N. R., Howland, W. C., Stevenson, D. D., & Spiegelberg, H. L. (1988) · American Review of Respiratory Disease · doi:10.1164/ajrccm/137.4.847 · Cited by 216
Cyclo‐oxygenase and nitric oxide synthase isoforms in rat carrageenin‐induced pleurisy
Tomlinson, A., Appleton, I., Moore, A. R., Gilroy, D. W., Willis, D., Mitchell, J. A., & Willoughby, D. A. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb17048.x · Cited by 216
Hyperkinesis and Learning Disabilities Linked to Artificial Food Flavors and Colors
Feingold, B. F. (1975) · The American Journal of Nursing · doi:10.2307/3423460 · Cited by 214
Combining ibuprofen and acetaminophen for acute pain management after third-molar extractions
Moore, P. A., & Hersh, E. V. (2013) · The Journal of the American Dental Association · doi:10.14219/jada.archive.2013.0207 · Cited by 214
Androgenetic alopecia and microinflammation
Mahé, Y. F., Michelet, J., Billoni, N., Jarrousse, F., BTS, Buan, B., BTS, Commo, S., BTS, Saint‐Léger, D., et al. (2000) · International Journal of Dermatology · doi:10.1046/j.1365-4362.2000.00612.x · Cited by 214
Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors
Harris, R. E., Beebe-Donk, J., & Alshafie, G. A. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-27 · Cited by 214
A tetrodotoxin-resistant sodium current mediates inflammatory pain in the rat
Khasar, S. G., Gold, M. S., & Levine, J. D. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00738-1 · Cited by 214
Pairet, M., & Engelhardt, G. (1996) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.1996.tb00144.x · Cited by 213
Nonsteroidal Anti-inflammatory Drugs and the Risk for Chronic Renal Disease
Sandler, D. P., Burr, F. R., & Weinberg, C. R. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-3-165 · Cited by 213
Yao, M., Kargman, S., Lam, E. C., Kelly, C. R., Zheng, Y., Luk, P., Kwong, E. C., Evans, J. F., & Wolfe, M. M. (2003) · PubMed · Cited by 213
Role of prostaglandins in the formation of aspirin-induced gastric ulcers
Konturek, S. J., Piastucki, I., Brzozowski, T., Radecki, T., Dembinska-Kiec, A., Źmuda, A., & Gryglewski, R. J. (1981) · Gastroenterology · doi:10.1016/0016-5085(81)90182-7 · Cited by 213
Siegel, M. I., McConnell, R. T., Abrahams, S. L., Porter, N. A., & Cuatrecasas, P. (1979) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(79)92146-6 · Cited by 213
Cyclooxygenase-2 and its role in ovulation: a 2004 account
Sirois, J., Sayasith, K., Brown, K. A., Stock, A. E., Bouchard, N., & Doré, M. (2004) · Human Reproduction Update · doi:10.1093/humupd/dmh032 · Cited by 212
Zhang, C., Baumgartner, R. A., Yamada, K., & Beaven, M. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.20.13397 · Cited by 212
Nonsteroidal Anti-Inflammatory Drugs for Postoperative Pain: A Focus on Children
Kokki, H. J. (2003) · Pediatric Drugs · doi:10.2165/00128072-200305020-00004 · Cited by 212
Needleman, P., Minkes, M. S., & DOUGLAS, J. R. (1974) · Circulation Research · doi:10.1161/01.res.34.4.455 · Cited by 212
The discovery of aspirin's antithrombotic effects.
Miner, J. J., & Hoffhines, A. J. (2007) · PubMed Central · Cited by 212
Raging the War Against Inflammation With Natural Products
Attiq, A., Jalil, J., Husain, K., & Ahmad, W. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00976 · Cited by 211
In vitro modulation of inflammatory cytokine and IgG levels by extracts of Perna canaliculus
Mani, S., & Lawson, J. W. (2006) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-6-1 · Cited by 211
In vitro effects of cyclooxygenase inhibitors in whole blood of horses, dogs, and cats
Brideau, C., Van Staden, C., & Chan, C. C. (2001) · American Journal of Veterinary Research · doi:10.2460/ajvr.2001.62.1755 · Cited by 210
Mechanisms of salicylate ototoxicity
Stypulkowski, P. H. (1990) · Hearing Research · doi:10.1016/0378-5955(90)90144-e · Cited by 210
An Intestinal Disease Produced Experimentally by a Prostaglandin Deficiency
Robert, A. (1975) · Gastroenterology · doi:10.1016/s0016-5085(19)32433-3 · Cited by 210
Singh, G. B., & Atal, C. K. (1986) · Inflammation Research · doi:10.1007/bf01965005 · Cited by 210
The cyclooxygenase theory of aspirin-induced asthma
Szczeklik, A. (1990) · European Respiratory Journal · doi:10.1183/09031936.93.03050588 · Cited by 210
Novel host response therapeutic approaches to treat periodontal diseases
Kirkwood, K. L., Cirelli, J. A., Rogers, J. E., & Giannobile, W. V. (2007) · Periodontology 2000 · doi:10.1111/j.1600-0757.2006.00166.x · Cited by 208
Bär, K., Natura, G., Telleria-Diaz, A., Teschner, P., Vogel, R., Vásquez, E., Schaible, H., & Ebersberger, A. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.0882-03.2004 · Cited by 208
Evans, A. M. (1992) · European Journal of Clinical Pharmacology · doi:10.1007/bf00266343 · Cited by 207
Acute Oliguric Renal Failure Induced by Indomethacin: Possible Mechanism
WALSHE, J. J., & VENUTO, R. C. (1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-91-1-47 · Cited by 207
Pickard, J. D., & MacKenzie, E. T. (1973) · Nature New Biology · doi:10.1038/newbio245187a0 · Cited by 207
Dual acting anti-inflammatory drugs: a reappraisal
Bertolini, A., Ottani, A., & Sandrini, M. (2001) · Pharmacological Research · doi:10.1006/phrs.2001.0872 · Cited by 206
Aspirin as a therapeutic agent in cardiovascular disease. Special Writing Group.
Fuster, V, Dyken, M. L., Vokonas, P. S., & Hennekens, C. (1993) · Circulation · doi:10.1161/01.cir.87.2.659 · Cited by 206
Hamulyák, E. N., Scheres, L. J. J., Marijnen, M. C., Goddijn, M., & Middeldorp, S. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012852.pub2 · Cited by 208
Physiological role of prostaglandins in the induction of ovulation
TSAFRIRI, A., Lindner, H. R., Zor, U., & Lamprecht, S. A. (1972) · Prostaglandins · doi:10.1016/0090-6980(72)90024-x · Cited by 206
Aiken, J. W. (1972) · Nature · doi:10.1038/240021a0 · Cited by 206
Nociception in cyclooxygenase isozyme-deficient mice
Ballou, L. R., Botting, R. M., Goorha, S., Zhang, J., & Vane, J. R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.180319297 · Cited by 205
Self-citationPyrogen fever and prostaglandin‐like activity in cerebrospinal fluid
Feldberg, W., & Gupta, K. P. (1973) · The Journal of Physiology · doi:10.1113/jphysiol.1973.sp010071 · Cited by 205
Structure and Ligand Based Drug Design Strategies in the Development of Novel 5- LOX Inhibitors
Aparoy, P., Kumar Reddy, K., & Reddanna, P. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712801661112 · Cited by 205
Cyclooxygenase 2 inhibitors: discovery, selectivity and the future
Marnett, L. J., & Kalgutkar, A. S. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01385-1 · Cited by 205
Carcinogenesis: Failure of resolution of inflammation?
Fishbein, A., Hammock, B. D., Serhan, C. N., & Panigrahy, D. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107670 · Cited by 205
Dirig, D. M., Isakson, P. C., & Yaksh, T. L. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37497-x · Cited by 205
COX-2 inhibitors in cancer treatment and prevention, a recent development
Xu, X.-C. (2002) · Anti-Cancer Drugs · doi:10.1097/00001813-200202000-00003 · Cited by 205
Coronary Vasoconstrictor Effect of Indomethacin in Patients with Coronary-Artery Disease
Friedman, P. L., Brown, E. J., Gunther, S., Alexander, R. W., Barry, W. H., Mudge, G. H., & Grossman, W. (1981) · New England Journal of Medicine · doi:10.1056/nejm198111123052002 · Cited by 205
O’Grady, J. P., Caldwell, B. V., Auletta, F. J., & Speroff, L. (1972) · Prostaglandins · doi:10.1016/0090-6980(72)90072-x · Cited by 203
Valent, P., & Bettelheim, P. (1992) · Advances in Immunology · doi:10.1016/s0065-2776(08)60879-2 · Cited by 202
The Foreign Body Response Demystified
Chandorkar, Y., K, R., & Basu, B. (2019) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.8b00252 · Cited by 201
Cyclooxygenase (COX) 1 and 2 in normal, inflamed, and ulcerated human gastric mucosa
Jackson, L. M., Wu, K. C., Mahida, Y. R., Jenkins, D., & Hawkey, C. J. (2000) · Gut · doi:10.1136/gut.47.6.762 · Cited by 201
Chen, C., Chang, F., Teng, C., & Wu, Y. (1999) · Journal of the Chinese Chemical Society · doi:10.1002/jccs.199900010 · Cited by 201
Indomethacin in submicromolar concentrations inhibits cyclic AMP-dependent protein kinase
Kantor, H. S., & Hampton, M. (1978) · Nature · doi:10.1038/276841a0 · Cited by 201
Hong, S. L., & Levine, L. (1976) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)33128-9 · Cited by 201
Inhibition of tumour growth in vivo and in vitro by prostaglandin E
SANTORO, M. G., Philpott, G. W., & Jaffe, B. M. (1976) · Nature · doi:10.1038/263777a0 · Cited by 201
Chan, F. K., & Leung, W. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11030-0 · Cited by 200
Rouzer, C. A., & Marnett, L. J. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00215 · Cited by 199
Kilbom, A., & Wennmalm, A. (1976) · The Journal of Physiology · doi:10.1113/jphysiol.1976.sp011358 · Cited by 199
Unmasking of thromboxane A2 synthesis by ureteral obstruction in the rabbit kidney
MORRISON, A. R., NISHIKAWA, K., & NEEDLEMAN, P. (1977) · Nature · doi:10.1038/267259a0 · Cited by 199
History of drugs for thrombotic disease. Discovery, development, and directions for the future.
Mueller, R. L., & Scheidt, S. (1994) · Circulation · doi:10.1161/01.cir.89.1.432 · Cited by 199
Metadata
- Authors
- VANE, J. R.
- Affiliations
- Royal College of Surgeons of England (GB)
- Corresponding author
- VANE, J. R.
- Venue
- Nature New Biology
- Published
- 1971-06
- Volume
- 231
- Issue
- 25
- Pages
- 232-235
- ISSN
- 0090-0028 (ISSN-L)
- 2058-1092
- OpenAlex
- W2008574207
- Cited by
- 8,605
- References
- 26
- Citations by year
- 2026: 51 · 2025: 72 · 2024: 86 · 2023: 106 · 2022: 117 · 2021: 121 · 2020: 118 · 2019: 114 · 2018: 123 · 2017: 150 · 2016: 144 · 2015: 154 · 2014: 154 · 2013: 162 · 2012: 190
- FWCI
- 183.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature New Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Physical Sciences › Chemistry › Organic Chemistry › Heterocyclic Compound Synthesis and Bioactivity
- Keywords
- aspirin, salicylates, prostaglandin synthesis inhibition, mechanism of action, guinea pig lung, anti-inflammatory agents
- MeSH terms
- Animals, Arachidonic Acids, Aspirin, Biological Assay, Chromatography, Thin Layer, Colon, Guinea Pigs, Indomethacin, Lung, Prostaglandins, Salicylates, Stomach, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.